ӣƵapp

[Skip to Navigation]
Sign In

September 3, 2024, Vol 332, No. 9, Pages 687-768 | e-Cigarettes

This Week in JAMA

Audio Highlights

Abstract Full Text
free access online only has audio
JAMA. 2024;332(9):e2318388. doi:10.1001/jama.2023.18388
Original Investigation

A Vaping Cessation Text Message Program for Adolescent E-Cigarette Users: A Randomized Clinical Trial

Abstract Full Text
has audio
JAMA. 2024;332(9):713-721. doi:10.1001/jama.2024.11057

This randomized clinical trial compares the effectiveness of a tailored, interactive text message program for nicotine vaping cessation vs assessment only among US adolescents aged 13-17 years.

Germline CDH1 Variants and Lifetime Cancer Risk

Abstract Full Text
JAMA. 2024;332(9):722-729. doi:10.1001/jama.2024.10852

This cross-sectional study describes the risk estimates for gastric and breast cancer for individuals with CDH1 variants.

Oral Antibiotics and Risk of Serious Cutaneous Adverse Drug Reactions

Abstract Full Text
JAMA. 2024;332(9):730-737. doi:10.1001/jama.2024.11437

This population-based case-control study assesses the association of commonly prescribed oral antibiotics with serious cutaneous adverse drug reactions and characterizes outcomes of patients hospitalized for them.

Research Letter

Variability in Constituents of E-Cigarette Products Containing Nicotine Analogues

Abstract Full Text
has audio
JAMA. 2024;332(9):753-755. doi:10.1001/jama.2024.12408

This study characterizes and quantifies constituents in 2 e-cigarette products to assess product consistency and inform future risk assessments.

Prevalence of Nicotine Pouch Use Among US Adults

Abstract Full Text
has audio
JAMA. 2024;332(9):755-757. doi:10.1001/jama.2024.10686

This cross-sectional study uses data from the 2022 Tobacco Use Supplement of the Current Population Survey to estimate the prevalence of adult US nicotine pouch use and the characteristics of the individuals using pouches.

Viewpoint

How Should Organizations Be Held Accountable for Clinician Well-Being?

Abstract Full Text
JAMA. 2024;332(9):699-700. doi:10.1001/jama.2024.12015

This Viewpoint summarizes methods used by health care organizations to assess and improve clinician well-being, discusses the potential downsides of public reporting of clinician well-being survey data, and calls for making organizations’ adherence to structure and process measures a part of accreditation criteria.

Major Gaps in the Cascade of Care for Opioid Use Disorder: Implications for Clinical Practice

Abstract Full Text
JAMA. 2024;332(9):701-702. doi:10.1001/jama.2024.11977

This Viewpoint examines a recent report that used data from the 2022 National Survey on Drug Use and Health to estimate the opioid cascade of care, a framework to characterize the adult US populations who needed and received opioid use disorder (OUD) treatment, as well as discusses ways in which clinicians can close gaps in care.

The Double-Edged Sword of Extremely High Prices for Gene Therapies in Sickle Cell Disease

Abstract Full Text
JAMA. 2024;332(9):703-704. doi:10.1001/jama.2024.11703

This Viewpoint discusses the high cost of new gene therapies for sickle cell disease, the challenges these costs pose for health care access, and new policy approaches to ensure fair reimbursement for payers and manufacturers without further increasing health care costs or barriers to access for underserved populations.

Health and the 2024 US Election

Checks and Balances on FDA’s Authority

Abstract Full Text
JAMA. 2024;332(9):705-706. doi:10.1001/jama.2024.11987

In this Viewpoint, the authors refute recent suggestions that the US Food and Drug Administration (FDA) is not accountable for its decisions, pointing out the legal, legislative, and executive checks and balances on the agency.

A Piece of My Mind

Both Sides Now

Abstract Full Text
JAMA. 2024;332(9):707-708. doi:10.1001/jama.2024.12440

In this narrative medicine essay, a pediatric and internal medicine physician and her husband reach a difficult crossroads upon learning that their unborn daughter has a severe heart defect.

Editorial

E-Cigarette Use in Adolescents and Adults—A JAMA Collection

Abstract Full Text
has audio
JAMA. 2024;332(9):709-710. doi:10.1001/jama.2024.15912

Supporting Adolescents’ Desire to Quit E-Cigarettes

Abstract Full Text
has audio
JAMA. 2024;332(9):711-712. doi:10.1001/jama.2024.13142
Review

Obesity in Adolescents: A Review

Abstract Full Text
has active quiz has audio
JAMA. 2024;332(9):738-748. doi:10.1001/jama.2024.11809

This Review summarizes the current evidence regarding the epidemiology, pathophysiology, diagnosis, and treatment of obesity in adolescents, with a focus on management of obesity.

JAMA Insights

Vaping in Youth

Abstract Full Text
has active quiz has audio
JAMA. 2024;332(9):749-750. doi:10.1001/jama.2024.13403

This JAMA Insights reviews the health effects of vaping among youth in the US and current recommendations for screening and treatment.

E-Cigarette Use in Adults

Abstract Full Text
has active quiz has audio
JAMA. 2024;332(9):751-752. doi:10.1001/jama.2024.8759

This JAMA Insights explores the adverse effects and health outcomes of e-cigarettes vs combusted cigarettes and the effectiveness of using e-cigarettes as a smoking cessation aid among US adults.

Medical News & Perspectives

US Surgeon General Vivek Murthy: To Protect Adolescents, Social Media Needs Warning Labels

Abstract Full Text
has multimedia has audio
JAMA. 2024;332(9):689-691. doi:10.1001/jama.2024.14245

This Medical News article is an interview with US Surgeon General Vivek Murthy, MD, MBA, and JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, about his call for a warning label on social media platforms.

Controversial FDA Decision Authorizes Menthol-Flavored E-Cigarettes Despite Risks to Youth

Abstract Full Text
has audio
JAMA. 2024;332(9):692-696. doi:10.1001/jama.2024.14243

This Medical News story examines the controversy surrounding the FDA’s first authorization of flavored e-cigarettes, in this case menthol.

Medical News in Brief

Study: Bird Flu in Dairy Cows May Spread More Easily to Other Mammals

Abstract Full Text
JAMA. 2024;332(9):697. doi:10.1001/jama.2024.14871

GLP-1 RA Drugs Not Associated With Increased Suicidal Thoughts

Abstract Full Text
JAMA. 2024;332(9):697. doi:10.1001/jama.2024.14872

One in 5 Children Have Autism If Older Sibling Does Too

Abstract Full Text
JAMA. 2024;332(9):697. doi:10.1001/jama.2024.14873

New Immunotherapy Shows Potential to Shrink Metastatic Solid Tumors

Abstract Full Text
JAMA. 2024;332(9):697. doi:10.1001/jama.2024.14874

Less Screen Time Linked to Improved Sociability and Behavior in Children

Abstract Full Text
JAMA. 2024;332(9):697-698. doi:10.1001/jama.2024.14875

WHO Approves First Self-Test for Hepatitis C

Abstract Full Text
JAMA. 2024;332(9):698. doi:10.1001/jama.2024.14876

Mediterranean Diet Linked to Better Heart Health in Children and Teens

Abstract Full Text
JAMA. 2024;332(9):698. doi:10.1001/jama.2024.14877

Study: Secondhand Tobacco Smoke Worse for Children Than E-Cigarette Vapor

Abstract Full Text
JAMA. 2024;332(9):698. doi:10.1001/jama.2024.14878
Poetry and Medicine

Laertes Loses His Memory

Abstract Full Text
JAMA. 2024;332(9):763. doi:10.1001/jama.2024.9593
JAMA Revisited

“Denicotinized” Tobacco

Abstract Full Text
JAMA. 2024;332(9):764. doi:10.1001/jama.2023.18403
JAMA Patient Page

What Are E-Cigarettes?

Abstract Full Text
free access has audio
JAMA. 2024;332(9):768. doi:10.1001/jama.2024.14334

This JAMA Patient Page describes e-cigarettes and the potential health effects of vaping.

Comment & Response

Prediction Models for Individualized Treatment Effects of Oxygen Targets

Abstract Full Text
JAMA. 2024;332(9):757-758. doi:10.1001/jama.2024.12035

Prediction Models for Individualized Treatment Effects of Oxygen Targets—Reply

Abstract Full Text
JAMA. 2024;332(9):758-759. doi:10.1001/jama.2024.12038

Pulmonary Vein Isolation and Left Atrial Appendage Ligation in Atrial Fibrillation

Abstract Full Text
JAMA. 2024;332(9):759. doi:10.1001/jama.2024.13523

Pulmonary Vein Isolation and Left Atrial Appendage Ligation in Atrial Fibrillation—Reply

Abstract Full Text
JAMA. 2024;332(9):760. doi:10.1001/jama.2024.13526

Review of Systemic Lupus Erythematous

Abstract Full Text
JAMA. 2024;332(9):760-761. doi:10.1001/jama.2024.13594

Review of Systemic Lupus Erythematous—Reply

Abstract Full Text
JAMA. 2024;332(9):761-762. doi:10.1001/jama.2024.13597
JAMA Masthead

JAMA

Abstract Full Text
free access
JAMA. 2024;332(9):687-688. doi:10.1001/jama.2023.18387
×